Trimethoprim-sulfamethoxazole (TMP-SMX)
| Effect of ECMO | Minimal impact on drug PK |
|---|---|
| Dose recommendation | ECMO-specific dose adjustment not required |
| Comments, reference | Case report, requires confirmation (Pharmacotherapy 2020;40:713). See also: Crit Care 2024;28:326. |